IntechOpen eBooks,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 23, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection
has
devastated
the
world
with
disease
2019
(COVID-19).
SARS-CoV-2
is
an
RNA
virus
that
a
high
mutation
rate
producing
new
variant
serious
threats.
Recently
emerged
delta
(B.1.617.2)
(India),
and
omicron
(B.1.1.529)
(South
Africa)
mutant
makes
more
attention
than
others
previously
known.
These
variants
exhibit
many
neurological
complications.
The
of
COVID-19
are
also
involved
in
gut
microbiota
dysbiosis,
thus
enhancing
inflammation
process
which
then
causes
stroke,
diabetes
thrombosis.
Administering
vaccines
crucial
due
to
continual
introduction
concern.
Therefore,
modified
have
been
thought
as
potential
vaccines.
Pediatric Reports,
Journal Year:
2024,
Volume and Issue:
16(2), P. 399 - 409
Published: May 14, 2024
Background.
The
emergence
of
the
Omicron
strain
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
at
end
December
2021
has
drastically
increased
number
infected
children
in
Japan,
along
with
febrile
convulsions,
but
its
clinical
impact
is
unclear.
Materials
and
Methods.
We
compared
frequency
SARS-CoV-2
infection
hospitalized
convulsions
fever
symptoms
without
convulsions.
Results.
In
2022,
49
58
required
emergency
hospitalization
for
(FC
group)
status
epilepticus
or
cluster
spasms,
which
24
38
underwent
a
Filmarray®
panel
test
(FA
test),
respectively,
others
received
quantitative
antigen
SARS-CoV-2.
only
six
patients
tested
positive
(10.3%,
6/58).
As
reference
group,
655
aged
<10
years
who
FA
during
same
period
were
investigated,
4
(1.8%,
4/223)
42
(9.7%,
42/432)
respectively.
Rhinovirus/enterovirus
(RV/EV)
was
most
frequently
detected
virus
(40.3%,
264/655),
followed
by
syncytial
(RSV)
(18.9%,
124/655)
parainfluenza
3
(PIV3)
(7.8%,
51/655).
There
no
significant
difference
trend
viruses
between
two
groups.
Conclusions.
severity
requiring
associated
may
be
similar
to
that
other
children.
Frontiers in Neurology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 10, 2024
Coronavirus
disease
2019
(COVID-19)
infection
has
been
associated
with
severe
neurological
consequences,
including
stroke
or
seizures,
and
less
sequelae,
headaches,
dizziness,
anosmia.
Earlier
COVID-19
variants
were
high
morbidity
mortality;
however,
knowledge
of
the
impact
conditions
in
setting
on
healthcare
outcomes
is
limited.
We
sought
to
determine
acute
inpatient
hospitalization
outcomes.
Clinical and Experimental Vaccine Research,
Journal Year:
2024,
Volume and Issue:
13(3), P. 175 - 175
Published: Jan. 1, 2024
Omicron
variants
present
new
challenges
when
it
comes
to
understanding
their
impact
on
vaccines,
antiviral
strategies,
and
possible
neurological
consequences.
This
article
describes
the
characteristics
of
variant,
its
epidemiology,
efficacy
vaccines
monoclonal
antibodies,
association
with
lymphoid
depletion.
We
also
explore
implications
Omicron,
focusing
encephalopathy
encephalitis.
There
are
unique
associated
which
is
characterized
by
distinct
mutations
increased
transmissibility.
For
a
better
effects
this
disease
developing
strategies
combat
spread,
especially
concerning
complications,
ongoing
research
necessary.
Brain Sciences,
Journal Year:
2024,
Volume and Issue:
14(11), P. 1161 - 1161
Published: Nov. 20, 2024
:
The
Omicron
variant
of
SARS-CoV-2
is
undergoing
constant
mutation.
New
strains
vary
in
neuropathogenicity
and
the
neurological
spectrum
disease.
aim
this
study
was
to
assess
frequency
clinical
characteristics
manifestations
during
dominance
among
hospitalized
patients,
including
differences
between
three
subsequent
periods.
IntechOpen eBooks,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 23, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection
has
devastated
the
world
with
disease
2019
(COVID-19).
SARS-CoV-2
is
an
RNA
virus
that
a
high
mutation
rate
producing
new
variant
serious
threats.
Recently
emerged
delta
(B.1.617.2)
(India),
and
omicron
(B.1.1.529)
(South
Africa)
mutant
makes
more
attention
than
others
previously
known.
These
variants
exhibit
many
neurological
complications.
The
of
COVID-19
are
also
involved
in
gut
microbiota
dysbiosis,
thus
enhancing
inflammation
process
which
then
causes
stroke,
diabetes
thrombosis.
Administering
vaccines
crucial
due
to
continual
introduction
concern.
Therefore,
modified
have
been
thought
as
potential
vaccines.
